The limitation of PET imaging for biological adaptive-IMRT assessed in animal models
- 1 April 2009
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 91 (1) , 101-106
- https://doi.org/10.1016/j.radonc.2008.11.014
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolismEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- FLT: Measuring Tumor Cell Proliferation In Vivo With Positron Emission Tomography and 3′-Deoxy-3′-[18F]FluorothymidineSeminars in Nuclear Medicine, 2007
- Hypoxia Imaging With FAZA-PET and Theoretical Considerations With Regard to Dose Painting for Individualization of Radiotherapy in Patients With Head and Neck CancerInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Fluorine-18-Labeled Fluoromisonidazole Positron Emission and Computed Tomography-Guided Intensity-Modulated Radiotherapy for Head and Neck Cancer: A Feasibility StudyInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Tumor microenvironment in head and neck squamous cell carcinomas: Predictive value and clinical relevance of hypoxic markers. A reviewHead & Neck, 2007
- [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: Clinical outcomes and patterns of failureInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Theragnostic imaging for radiation oncology: dose-painting by numbersThe Lancet Oncology, 2005
- Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II—clinical resultsInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Intensity-modulated radiation therapy for head and neck cancerExpert Review of Anticancer Therapy, 2004
- A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 2001